Tag: Antitrust Improvements
US: Bristol-Myers licensing 2 compounds to raise assets
Bristol-Myers Squibb announced on Thursday that it has entered into two separate agreements with Biogen and Roche Holding to license Anti-eTau and Anti-Myostatin Compounds,...
US: FTC Revises Hart-Scott-Rodino thresholds
The Federal Trade Commission announced on January 19, 2017 increased jurisdictional thresholds for premerger notification filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,...
